Renal Business Today

Genzyme Corp.

Sanofi Names New CEO of Genzyme

PARIS—Sanofi has named David Meeker as Chief Executive Officer of Genzyme, a Sanofi company, effective November 1. ...More
October 24, 2011
Posted in News, Business
Sanofi Aventis Acquires Genzyme for $20.1 Billion

CAMBRIDGE, Mass.—Sanofi-aventis will acquire Genzyme Corp. for $74 per share in cash, or approximately $20.1 billion, according to a Feb. 16 news release. ...More
February 16, 2011
Posted in News, Business, Government & Regulation
FDA Approves Hectorol Vial Dosing Option

CAMBRIDGE, Mass.—The U.S. Food and Drug Administration (FDA) has approved a 2 mcg/mL vial dosing option of Hectorol (doxercalciferol injection), for the treatment of secondary hyperparathyroidism in patients with CKD on dialysis, according to a Dec. 22 news release. ...More
December 22, 2010
Posted in News, Clinical & Pharma, Government & Regulation
LabCorp Buys Genzyme's Genetic Testing Business

CAMBRIDGE, Mass.—Genzyme Corp. announced Dec. 1 that it has completed the sale of Genzyme Genetics to Laboratory Corporation of America Holdings for $925 million in cash. ...More
December 1, 2010
Posted in News, Business
Genzyme Board Rejects Sanofi Aventis Offer

CAMBRIDGE, Mass.—Genzyme Corp. said Oct. 7 that its board of directors has voted unanimously to reject the unsolicited $69 per share tender offer from Sanofi-Aventis, and the board recommends that Genzyme shareholders not tender their shares to Sanofi-Aventis pursuant to ...More
October 8, 2010
Posted in News, Business
AKF Gala Raises Nearly $800,000

WASHINGTON—The American Kidney Fund’s second annual national gala, The Hope Affair, on Sept. 28 raised nearly $800,000 for the programs and services of the AKF. ...More
October 4, 2010
Posted in News, Business
AFK 'Hope Affair' to Take Place Sept. 28

WASHINGTON—The second annual American Kidney Fund national gala, The Hope Affair, will take place on Tuesday, Sept. 28, at the Andrew W. Mellon Auditorium in Washington, DC. ...More
September 24, 2010
Posted in News, Business
Genzyme Sells Genetic Testing Business to LabCorp

CAMBRIDGE, Mass—Genzyme Corp. announced Sept. 13 that it has agreed to sell its genetic testing business to Laboratory Corporation of America Holdings for $925 million. ...More
September 13, 2010
Posted in News, Business
Genzyme 'Encouraged' by Oral-Drug Delay in Bundle

CAMBRIDGE, Mass.—In a July 27 news release, Genzyme Corp. said it was “encouraged” by the Centers for Medicare & Medicaid Services’ (CMS) decision not to immediately include oral medications without IV equivalents in the newly released dialysis bundled payment system. ...More
July 27, 2010
Posted in News, Business
Financial Analyst Reaction to Bundling Mixed

The dialysis bundle rule is in, and financial analysts are starting to weigh in on its impact on the business side of dialysis. ...More
July 27, 2010
Posted in Blog, Business